![]() |
市场调查报告书
商品编码
1734815
2032 年尿流率计市场预测:按产品类型、模式、技术、应用、最终用户和地区进行的全球分析Urine Flow Meters Market Forecasts to 2032 - Global Analysis By Product Type, Modality (Portable Urine Flow Meters and Stationary Urine Flow Meters), Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球尿流计市场预计在 2025 年将达到 3,010 万美元,预计到 2032 年将达到 5,130 万美元,预测期内的复合年增长率为 7.9%。
尿流计是医疗设备。它可以帮助评估肾功能、诊断泌尿道问题以及监测闭尿症和尿失禁等状况。这些仪器通常用于医院和泌尿系统等临床环境,提供重要数据,使医生能够有效地诊断和治疗各种泌尿系统疾病。
根据美国国家糖尿病、消化和肾臟疾病研究所 (NIDDK) 的数据,美国有超过 3000 万成年人患有慢性肾臟病。
泌尿系统疾病盛行率不断上升
前列腺增生、尿失禁和膀胱功能障碍等泌尿系统疾病的盛行率不断上升是尿流量计市场的主要驱动力。全球老龄人口不断增加,加上人们生活方式的改变和泌尿系统健康意识的增强,导致诊断程序激增。此外,医疗保健基础设施的进步和对疾病早期发现的日益重视,也推动了对准确、高效的尿流计设备的需求。预计这一趋势将持续下去,并大大促进尿液流量计市场的扩张。
替代诊断方法的可用性
许多医疗保健提供者更喜欢替代方法,因为它们具有更广泛的诊断能力和患者舒适度。此外,这些方法通常提供更全面的信息,减少对独立尿流计的依赖。此外,成本和先进诊断技术的取得进一步限制了已开发地区尿流计的采用,对市场发展带来了挑战。
开发整合且易于使用的仪器
製造商正专注于设计结合多种诊断功能、提供无线连接和即时数据分析的设备。数位健康平台和行动应用程式的整合将改善患者监测和医生的可近性。此外,其用户友好的介面和紧凑的设计使这些设备适用于临床和居家照护环境。此类技术创新可望提高采用率,尤其是在新兴经济体,并为市场扩张开闢新的途径。
严格的监管环境
监管机构对设备核准实施严格的标准,包括安全性、有效性和品质保证。遵守各种国际法规可能会延迟产品发布并增加製造商的开发成本。此外,监管指南的频繁更新需要持续投资于研究和文献,这可能会对新进入者造成障碍。
COVID-19 疫情对尿流量计市场产生了各种影响。最初,由于选择性手术的延迟和医院就诊人数的减少,需求暂时下降。然而,随着医疗保健系统的适应,对远端监控和家庭诊断的重新关注有助于支持市场的復苏。此外,疫情加速了数位医疗的普及,促使製造商开发更用户友善、互联互通的设备。总体而言,儘管短期内市场波动明显,但预计在后疫情时代市场将展现韧性并重获动力。
有线尿流计市场预计将在预测期内占据最大份额
预计有线尿流计部分将在预测期内占据最大的市场占有率。这一优势归因于其可靠性、准确性和成本效益,在医院和诊断中心广泛采用。此外,有线设备因其性能稳定且易于与现有医院基础设施整合而更受青睐。此外,已建立的临床效用和医疗保健专业人员的熟悉度将继续推动需求。
预计预测期内基于 PC 的尿流计部分将以最高的复合年增长率增长。
预计基于 PC 的尿液流量计部分将在预测期内呈现最高的成长率。这种快速扩张是由数位医疗解决方案的日益普及以及先进的数据分析软体的整合所推动的。此外,基于 PC 的系统还提供增强的功能,例如即时监控、资料储存和远端共用功能,这对临床医生和患者都具有极大的吸引力。此外,远端医疗和个人化医疗的兴起趋势预计将进一步推动需求。
预计北美地区将在预测期内占据最大的市场占有率。这种领先地位主要归功于该地区完善的医疗保健基础设施、泌尿系统疾病的高发性以及主要市场参与者的强大影响力。此外,优惠的报销政策和不断增加的医疗保健支出也支持了先进诊断设备的采用。此外,持续的研究开发和创新技术的早期采用进一步增强了北美的优势。
预计亚太地区在预测期内的复合年增长率最高。这种强劲的成长是由于医疗保健意识的提高、医疗保健基础设施投资的增加以及易患泌尿系统疾病的老年人口的增加。此外,政府为提高诊断能力和扩大私人医疗设施所采取的措施也有助于市场渗透。此外,亚太地区庞大且多样化的患者群体,加上快速的都市化和经济发展,预计将加速尿流量计的采用,使亚太地区成为成长最快的区域市场。
According to Stratistics MRC, the Global Urine Flow Meters Market is accounted for $30.1 million in 2025 and is expected to reach $51.3 million by 2032 growing at a CAGR of 7.9% during the forecast period. Urine flow meters are medical devices used to measure the volume and flow rate of urine over a specified period. They help in assessing kidney function, diagnosing urinary tract issues, and monitoring conditions like urinary retention or incontinence. These meters are often employed in clinical settings such as hospitals or urology departments, providing essential data for doctors to diagnose and manage various urinary disorders effectively.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), over 30 million adults in the U.S. are affected by chronic kidney disease.
Rising prevalence of urological disorders
The increasing prevalence of urological disorders, such as benign prostatic hyperplasia, urinary incontinence, and bladder dysfunction, is a major driver for the urine flow meters market. The global rise in aging populations, coupled with lifestyle changes and higher awareness about urological health, has led to a surge in diagnostic procedures. Furthermore, advancements in healthcare infrastructure and the growing emphasis on early disease detection are fueling demand for accurate and efficient urine flow measurement devices. This trend is expected to continue, thereby significantly contributing to the expansion of the urine flow meters market.
Availability of alternative diagnostic methods
Many healthcare providers prefer these alternatives due to their broader diagnostic capabilities and patient comfort. Additionally, these methods often provide more comprehensive information, reducing the reliance on standalone urine flow meters. Moreover, cost considerations and accessibility of advanced diagnostic technologies in developed regions further limit the adoption of urine flow meters, posing a challenge to the market's growth.
Development of integrated and user-friendly
Manufacturers are focusing on designing devices that combine multiple diagnostic features, offer wireless connectivity, and provide real-time data analysis. The integration of digital health platforms and mobile applications enhances patient monitoring and physician accessibility. Furthermore, user-friendly interfaces and compact designs are making these devices more suitable for both clinical and home care settings. Such innovations are expected to drive adoption rates and open new avenues for market expansion, particularly in emerging economies.
Stringent regulatory landscape
Regulatory authorities impose rigorous standards for device approval, encompassing safety, efficacy, and quality assurance. Compliance with varying international regulations can delay product launches and increase development costs for manufacturers. Moreover, frequent updates to regulatory guidelines necessitate continuous investment in research and documentation, potentially hindering the entry of new players.
The Covid-19 pandemic had a mixed impact on the urine flow meters market. Initially, the postponement of elective procedures and reduced hospital visits led to a temporary decline in demand. However, as healthcare systems adapted, there was a renewed focus on remote monitoring and home-based diagnostics, which supported market recovery. Additionally, the pandemic accelerated digital health adoption, prompting manufacturers to develop more user-friendly and connected devices. Overall, while short-term disruptions were evident, the market demonstrated resilience and is expected to regain momentum in the post-pandemic era.
The wired urine flow meters segment is expected to be the largest during the forecast period
The wired urine flow meters segment is expected to account for the largest market share during the forecast period. This dominance can be attributed to their widespread adoption in hospitals and diagnostic centers due to their reliability, accuracy, and cost-effectiveness. Furthermore, wired devices are preferred for their consistent performance and ease of integration with existing hospital infrastructure. Additionally, their established clinical utility and familiarity among healthcare professionals contribute to sustained demand.
The PC-based urinary flow meters segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the PC-based urinary flow meters segment is predicted to witness the highest growth rate. This rapid expansion is driven by the increasing adoption of digital healthcare solutions and the integration of advanced software for data analysis. Moreover, PC-based systems offer enhanced functionality, including real-time monitoring, data storage, and remote sharing capabilities, making them highly attractive for both clinicians and patients. Additionally, the growing trend toward telemedicine and personalized healthcare is expected to further propel the demand.
During the forecast period, the North America region is expected to hold the largest market share. This leadership is primarily due to the region's well-established healthcare infrastructure, high prevalence of urological disorders, and strong presence of leading market players. Additionally, favorable reimbursement policies and increased healthcare spending support the adoption of advanced diagnostic devices. Moreover, ongoing research and development activities, coupled with early adoption of innovative technologies, further strengthen North America's position as the dominant force.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This robust growth is driven by rising healthcare awareness, increasing investments in healthcare infrastructure, and a growing geriatric population susceptible to urological conditions. Furthermore, government initiatives to improve diagnostic capabilities and the expansion of private healthcare facilities are boosting market penetration. Additionally, the region's large and diverse patient pool, coupled with rapid urbanization and economic development, is expected to accelerate the adoption of urine flow meters, making Asia Pacific the fastest-growing regional market.
Key players in the market
Some of the key players in Urine Flow Meters Market include Laborie Medical Technologies, Medica S.p.A., Apex MediTech, tic Medizintechnik GmbH & Co. KG, MINZE HEALTH, Oruba Technology & Innovation, Status Medical Equipments, Prometheus Group, Albyn Medical SL, Best Smart Medical LLC, DANTEC DYNAMICS AS, Foresight Technologies Inc., HC Italia srl, Mcube Technology Co. Ltd., RECO MEDIZINTECHNIK WOLFGANG RENTSCH eK, Santron Meditronic, SCHIPPERS MEDIZINTECHNIK and SRS Medical.
In March 2024, Laborie invested in iO Urology, the developer of CarePath(R), an FDA-approved at-home uroflow device with embedded cellular connectivity. This device enables remote monitoring and patient education for conditions like Benign Prostatic Hyperplasia (BPH).
In April 2023, Status Medical Equipments India Pvt Limited received a manufacturing license from the Central Drugs Standard Control Organization (CDSCO) for their Class B devices, including uroflowmeters, urodynamic measurement systems, and pneumatic lithotripters.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.